Reduced Toxicity SCT for HLH: Which is the Best Approach

Track: Pediatric BMT Program
Thursday, February 27, 2014, 3:00 PM-4:30 PM
Grapevine A (Gaylord Texan)
Paul Veys, MD , NHS Foundation Trust, Great Ormond Street Hospital for Children, London, United Kingdom
Disclosures:
P. Veys, Astellas Pharma Europe Ltd, none: Honoraria
See more of: (PEDS) HLH
See more of: Pediatric BMT Program